6-K - Mesoblast Limited | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Mesoblast Limited filed Exhibit 99.1 containing four Appendix 3Y Change of Director’s Interest Notices disclosing issuances of options to directors Dr Silviu Itescu (2,025,600 options on 17 March 2026), Dr Eric Rose (820,000 options on 18 March 2026), Gregory George (200,000 options on 16 March 2026), and Lyn Cobley (200,000 options on 18 March 2026), approved at the 2025 AGM for nil consideration.

Key Takeaways

1Dr Silviu Itescu acquired 2,025,600 options on 2026-03-17, increasing total options to 18,475,158 while holding 78,958,928 ordinary shares.

2Dr Eric Rose acquired 820,000 options on 2026-03-18, increasing total options to 6,413,451 while holding 6,749,274 ordinary shares (including 71,472 ADS).

3Gregory George acquired 200,000 options to acquire ordinary shares on 2026-03-16 under the Employee Share Option Plan.

4Lyn Cobley acquired 200,000 options on 2026-03-18 while holding 30,000 direct and 33,000 indirect ordinary shares.

Current Report Details

Event Type

Management Change

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Management Change

Executive & Director Changes

Dr Silviu Itescu

Director

options granted

Effective: 2026-03-17

Issue of options with approval by shareholders at the 2025 AGM

Dr Eric Rose

Director

options granted

Effective: 2026-03-18

Issue of options with approval by shareholders at the 2025 AGM

Gregory George

Director

options granted

Effective: 2026-03-16

Options issued in accordance with the Company’s Employee Share Option Plan and approved at the Company’s 2025 AGM

Lyn Cobley

Director

options granted

Effective: 2026-03-18

Issue of options with approval by shareholders at the 2025 AGM

Exhibits (3)

6-K

99.1

EX-99.1

99.2

EX-99.2